Gut microbiota and clinical response to immune checkpoint inhibitor therapy in patients with advanced cancer by John Wen-Cheng Chang, Jia-Juan Hsieh, Chih-Yu Tsai, Horng-Yih Chiu, Yu-Feng Lin, Chiao-En Wu, Yung-Chi Shen, Ming-Mo Hou, Chieh-Ying Chang, Jian-An Chen, Chyi-Liang Chen, Cheng-Tang Chiu, Yuan-Ming Yeh, Cheng-Hsun Chiu

Get full text

Phase IA/IB study of single-agent tislelizumab, an investigational anti-PD-1 antibody, in solid tumors by Yun Zhang, Bhumsuk Keam, Jayesh Desai, Ben Markman, Shahneen Sandhu, Michael Millward, Yoon-Koo Kang, Chia-Chi Lin, Yee Chao, Sanjeev Deva, Jong Seok Lee, Chia-Jui Yen, Michael Jameson, Ming-Mo Hou, Chang-Hsien Lu, Kun-Ming Rau, Kyung-Hun Lee, Lisa Horvath, Michael Friedlander, Andrew Hill, Paula Barlow, Chi-Yuan Wu, Liang Liang, John Wu, Virginia Paton

Get full text